Following on from information provided to NICE by the company in June 2017, the appraisal of Heart failure (oedema) - furosemide micro-pump was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.
 
Status Discontinued
Technology type Medicine
Decision Selected
Process TA
ID number 1061

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
16 November 2022 Discontinued. Following on from information provided to NICE by the company in June 2017, the appraisal of Heart failure (oedema) - furosemide micro-pump was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.
03 July 2017 Following on from advice received from the company, the dates for this appraisal will be confirmed once regulatory approval timelines are established.
21 April 2017 Referral
21 April 2017 In progress. Topic referred
18 November 2016 - 16 December 2016 Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

For further information on our processes and methods, please see our CHTE processes and methods manual